AU2003269380A1 - Quinuclidinium derivatives as antimuscarinic agents - Google Patents

Quinuclidinium derivatives as antimuscarinic agents

Info

Publication number
AU2003269380A1
AU2003269380A1 AU2003269380A AU2003269380A AU2003269380A1 AU 2003269380 A1 AU2003269380 A1 AU 2003269380A1 AU 2003269380 A AU2003269380 A AU 2003269380A AU 2003269380 A AU2003269380 A AU 2003269380A AU 2003269380 A1 AU2003269380 A1 AU 2003269380A1
Authority
AU
Australia
Prior art keywords
quinuclidinium
derivatives
antimuscarinic agents
antimuscarinic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269380A
Other languages
English (en)
Inventor
John Gregory Slatter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2003269380A1 publication Critical patent/AU2003269380A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2003269380A 2002-10-29 2003-10-17 Quinuclidinium derivatives as antimuscarinic agents Abandoned AU2003269380A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42195102P 2002-10-29 2002-10-29
US60/421,951 2002-10-29
PCT/IB2003/004641 WO2004039801A1 (en) 2002-10-29 2003-10-17 Quinuclidinium derivatives as antimuscarinic agents

Publications (1)

Publication Number Publication Date
AU2003269380A1 true AU2003269380A1 (en) 2004-05-25

Family

ID=32230292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269380A Abandoned AU2003269380A1 (en) 2002-10-29 2003-10-17 Quinuclidinium derivatives as antimuscarinic agents

Country Status (7)

Country Link
US (1) US20040138253A1 (es)
JP (1) JP2006511494A (es)
AU (1) AU2003269380A1 (es)
BR (1) BR0315784A (es)
CA (1) CA2503654A1 (es)
MX (1) MXPA05003398A (es)
WO (1) WO2004039801A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175689A1 (en) * 2003-10-27 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Coated fine particles containing drug for intrabuccally fast disintegrating tablet
US8039482B2 (en) * 2004-03-25 2011-10-18 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
WO2006035280A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases
EP1832288B1 (en) * 2004-12-27 2012-06-20 Astellas Pharma Inc. Stable granular pharmaceutical composition of solifenacin or its salt
US7815939B2 (en) * 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
EP2046751A4 (en) * 2006-07-19 2010-12-29 Reddys Lab Ltd Dr PROCESS FOR PRODUCING SOLIFENACIN AND ITS SALTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
IL91377A (en) * 1988-09-14 1996-09-12 Nippon Shinyaku Co Ltd Derivatives of botinylamine glycolate
WO1992004346A1 (en) * 1990-09-06 1992-03-19 Pfizer Limited Antimuscarinic bronchodilators
US5512574A (en) * 1994-12-21 1996-04-30 American Home Products Corporation Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav

Also Published As

Publication number Publication date
JP2006511494A (ja) 2006-04-06
BR0315784A (pt) 2005-09-20
US20040138253A1 (en) 2004-07-15
WO2004039801A1 (en) 2004-05-13
MXPA05003398A (es) 2005-06-22
CA2503654A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2003245700A1 (en) Pyrazolopyridine derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
EP1583537A3 (en) Piperidine compounds as antibacterials
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003220050A1 (en) Vertical multipack
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003270297A1 (en) Toolholder
AU2003268304A1 (en) Toolholder
AU2003227712A1 (en) Tetrahydroisoquinoline derivatives
AU2003273989A1 (en) Quinazolinone derivatives useful as anti-hyperalgesic agents
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003290216A1 (en) Porphyrin derivatives
AU2003281366A1 (en) 1-aralkyl-n-(3-quinolyl)-1-cyclohexanecarboxamide derivative
AU2003257637A1 (en) Proline derivatives
AU2003902882A0 (en) Piperidyl derivatives
AU2003269380A1 (en) Quinuclidinium derivatives as antimuscarinic agents
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003282510A1 (en) Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase